# Sunitinib in Metastatic Renal Cancer

> **NCT01034878** · PHASE2 · COMPLETED · sponsor: **Istituto Clinico Humanitas** · enrollment: 25 (actual)

## Conditions studied

- Carcinoma, Renal Cell

## Interventions

- **DRUG:** Sunitinib

## Key facts

- **NCT ID:** NCT01034878
- **Lead sponsor:** Istituto Clinico Humanitas
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-12
- **Primary completion:** 2014-12
- **Final completion:** 2014-12
- **Target enrollment:** 25 (ACTUAL)
- **Last updated:** 2014-12-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01034878

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01034878, "Sunitinib in Metastatic Renal Cancer". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01034878. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*